Drug profile · INN
ceftobiprole
ZEFTERA (PREVIOUSLY ZEVTERA)
ceftobiprole (ZEFTERA (PREVIOUSLY ZEVTERA)) is a bacterial penicillin-binding protein inhibitor.
EMA: refused Antiinfectives for systemic use (J01) J01DI01
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — ceftobiprole
- Class
- Antiinfectives for systemic use (J01)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
ceftobiprole (ZEFTERA (PREVIOUSLY ZEVTERA)) is a bacterial penicillin-binding protein inhibitor.
Key facts
INN ceftobiprole
Brand ZEFTERA (PREVIOUSLY ZEVTERA)
Mechanism Bacterial penicillin-binding protein inhibitor
Target Bacterial penicillin-binding protein
Therapeutic class Antiinfectives for systemic use (J01)
ATC code J01DI01
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | refused | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ceftobiprole?
ceftobiprole (ZEFTERA (PREVIOUSLY ZEVTERA)) is a bacterial penicillin-binding protein inhibitor.
What is the brand name for ceftobiprole?
ZEFTERA (PREVIOUSLY ZEVTERA) is a marketed brand name for ceftobiprole. Check FDA Drugs@FDA for the current US label holder and prescribing information.